Jerod Denton
-
Vanderbilt, Ono Pharmaceutical extend drug discovery agreement
Vanderbilt University Medical Center (VUMC), Vanderbilt University and Japan-based Ono Pharmaceutical Co. Ltd. have expanded a drug discovery agreement initiated in 2015 that will now run through 2019. Read MoreMay 25, 2017
-
Emerging Scholar
Rene Raphemot, Ph.D., a National Institutes of Health postdoctoral fellow at Duke University, delivered the inaugural Discovery Science Emerging Scholars Lecture at Vanderbilt University School of Medicine last week. Read MoreMar 23, 2017
-
Investigators explore new way to control mosquitoes
In a new study, Vanderbilt pharmacologist Jerod Denton, Ph.D., Ohio State entomologist Peter Piermarini, Ph.D., and colleagues report an experimental molecule that inhibits kidney function in mosquitoes and thus might provide a new way to control the deadliest animal on Earth. Read MoreDec 1, 2016
-
Vanderbilt, Ono Pharmaceutical sign drug discovery agreement
Vanderbilt University Medical Center and Ono Pharmaceutical Group, an international company based in Japan, have signed a drug discovery agreement. Read MoreDec 10, 2015
-
Channel drug restores glucose balance
A new compound that activates potassium channels could be used to treat disorders of glucose homeostasis. Read MoreApr 16, 2014
-
Chemical causes kidney failure in mosquitoes: study
Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE. Read MoreMay 31, 2013
-
VU researcher has personal motive for investigating malaria
Vanderbilt researcher and Gabon, Africa, native is working to discover ways to kill malaria-spreading mosquitoes. Read MoreFeb 3, 2012